Consistent with the effect of eIF4E on cell proliferation, we found that silencing eIF4E also enhanced the capacity of ATRA or ATPR to induce AML cell differentiation, characterized by a further elevation in CD11b-positive cell ratio and morphological maturity. The gene discussed is ITGAM; the disease is acute myeloid leukemia.